ABVC BioPharma Inc Ownership
$1.15
6.48%
Nasdaq, Sep 17, 04:27 pm EDT.
Closed.
ABVC BioPharma Inc Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Jiang (Shuling)
|
3.073m | 11.93% | — | Feb 27 2026 |
| 2 |
YuanGene, Corp
|
829.699k | 3.22% | — | Feb 27 2026 |
| 3 |
Jiang (Tsung-Shann)
|
375.990k | 1.46% | — | Feb 27 2026 |
| 4 |
Geode Capital Management, L.L.C.
|
221.169k | 0.86% | +18.804k | Mar 31 2026 |
| 5 |
Vanguard Capital Management, LLC
|
190.574k | 0.74% | +190.574k | Mar 31 2026 |
|
1
Jiang (Shuling)
|
11.93%
3.073m
|
|
2
YuanGene, Corp
|
3.22%
829.699k
|
|
3
Jiang (Tsung-Shann)
|
1.46%
375.990k
|
|
4
Geode Capital Management, L.L.C.
|
0.86%
221.169k
|
|
5
Vanguard Capital Management, LLC
|
0.74%
190.574k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 18.20% of ABVC BioPharma Inc, with Jiang (Shuling) the biggest at 11.93%, followed by YuanGene, Corp (3.22%) and Jiang (Tsung-Shann) (1.46%). |
ABVC BioPharma Inc Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in ABVC BioPharma Inc has held steady at around 2.4% of the float over the past 12 months. Short sellers' positioning has barely changed in this period. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
